Spark Spine received a Notice of Allowance from the USPTO covering core intellectual property that protects the company’s proprietary spinal implant architectures, which underpin next-generation products for spinal fusion. Spark Spine expects the formal patent to be issued within the coming months.
The allowed claims cover key aspects of Spark Spine’s EMP implant systems, which are designed to generate small electrical signals in response to biomechanical forces through proprietary implant architecture. In Spark’s first-generation products for spinal fusion, EMP is intended to create localized electrical charges at the implant surface. This intellectual property strengthens the company’s ability to protect its platform and pursue future commercialization and market expansion.
“Receiving this Notice of Allowance is a pivotal moment for Spark Spine,” said Luke Diehl, Spark’s VP of Business Development. “It reflects that our team has created something fundamentally new, not an obvious iteration of old ideas. From a business perspective, this IP creates a formidable barrier to entry for competitors, and it shows clinicians that our platform technology is both unique and meaningful.”
“These claims are the bedrock of our portfolio,” added Spark President Kevin Chappuis. “It protects the specific architecture that makes our EMP technology function. With this allowance, we will continue to drive the next phase of our growth and develop our transformative solutions for surgeons and patients worldwide.”
Spark Spine received a Notice of Allowance from the USPTO covering core intellectual property that protects the company's proprietary spinal implant architectures, which underpin next-generation products for spinal fusion. Spark Spine expects the formal patent to be issued within the coming months.
The allowed claims cover key aspects of Spark...
Spark Spine received a Notice of Allowance from the USPTO covering core intellectual property that protects the company’s proprietary spinal implant architectures, which underpin next-generation products for spinal fusion. Spark Spine expects the formal patent to be issued within the coming months.
The allowed claims cover key aspects of Spark Spine’s EMP implant systems, which are designed to generate small electrical signals in response to biomechanical forces through proprietary implant architecture. In Spark’s first-generation products for spinal fusion, EMP is intended to create localized electrical charges at the implant surface. This intellectual property strengthens the company’s ability to protect its platform and pursue future commercialization and market expansion.
“Receiving this Notice of Allowance is a pivotal moment for Spark Spine,” said Luke Diehl, Spark’s VP of Business Development. “It reflects that our team has created something fundamentally new, not an obvious iteration of old ideas. From a business perspective, this IP creates a formidable barrier to entry for competitors, and it shows clinicians that our platform technology is both unique and meaningful.”
“These claims are the bedrock of our portfolio,” added Spark President Kevin Chappuis. “It protects the specific architecture that makes our EMP technology function. With this allowance, we will continue to drive the next phase of our growth and develop our transformative solutions for surgeons and patients worldwide.”
Copy to clipboard 
